Bugworks Research Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $6.78M

  • Investors
  • 23

Bugworks Research General Information

Description

Developer of a novel class of antibiotic drugs designed to tackle the problem of antimicrobial resistance. The company's platform produces multiple broad-spectrum assets and has expertise in the areas of cancer biology and immunology, enabling healthcare providers to reduce efflux-mediated drug resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 13962 Pierce Road
  • Saratoga, CA 95070
  • United States
+1 (818) 000-0000

Bugworks Research Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bugworks Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B2) 08-Mar-2024 $6.78M 000.00 00000 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series B1) Cancelled Clinical Trials - Phase 1
8. Later Stage VC (Series B1) 08-Nov-2021 0000 000.00 0000 Completed Clinical Trials - Phase 1
7. Early Stage VC (Series B) 23-Apr-2020 00.000 000.00 000.00 Completed Clinical Trials - Phase 1
6. Grant 08-Dec-2019 000 000.00 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series A) 13-Aug-2018 000 000.00 0000 Completed Product In Beta Test
4. Grant 24-Jul-2017 00.00 00.000 Completed Product In Beta Test
3. Seed Round 20-Nov-2015 00.000 00.000 00.00 Completed Product In Beta Test
2. Accelerator/Incubator 19-Jul-2014 Completed Product In Beta Test
1. Grant 04-Feb-2014 $500K Completed Product In Beta Test
To view Bugworks Research’s complete valuation and funding history, request access »

Bugworks Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 3,537,819 $0.000100 1% $1.7 $1.7 1x $1.7 8.74%
Seed 4,126,230 $0.000100 $0.63 $0.63 1x $0.63 10.19%
To view Bugworks Research’s complete cap table history, request access »

Bugworks Research Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel class of antibiotic drugs designed to tackle the problem of antimicrobial resistance. The company's
Drug Discovery
Saratoga, CA
42 As of 2024
000.00
00000 0000-00-00
00000000000 000.00

000000

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000 000000000
Malvern, PA
00 As of 0000
00000
0000000000 0 00000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000 000000000
Brighton, United Kingdom
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bugworks Research Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Venatorx Pharmaceuticals Venture Capital-Backed Malvern, PA 00 00000 0000000000 0 00000
Destiny Pharma Formerly PE-Backed Brighton, United Kingdom 00 000.00 00000000 000.00
BioVersys Venture Capital-Backed Basel, Switzerland 00 00000 00000 00000
Entasis Therapeutics Corporate Backed or Acquired Waltham, MA 00 00000 000000&0 00000
Synlogic Formerly VC-backed Cambridge, MA 0 00000 00000000 00000
You’re viewing 5 of 25 competitors. Get the full list »

Bugworks Research Patents

Bugworks Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3228180-A1 Antibiotic pyrazinothiazine derivatives and process of preparation thereof Pending 13-Aug-2021 0000000000
US-20230167119-A1 Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist Pending 09-Jan-2021 0000000000
AU-2022206418-A1 Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist Pending 09-Jan-2021 0000000000
EP-4121431-A1 Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist Pending 09-Jan-2021 0000000000
CA-3172939-A1 Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2a receptor and adenosine 2b receptor antagonist Pending 09-Jan-2021 C07D487/04
To view Bugworks Research’s complete patent history, request access »

Bugworks Research Executive Team (9)

Name Title Board Seat Contact Info
Anand Anandkumar Ph.D Co-Founder, Chief Executive Officer, Managing Director & Board Member
Venkataraman Balasubramanian Ph.D Co-Founder, President, Chief Operating Officer & Board Member
Shahul Hameed Co-Founder, Chief Scientific Officer & Board Member
Santanu Datta Ph.D Co-Founder, Chief Mentor & Board Member
Vasanthi Ramachandran Vice President of Collaborations & Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

Bugworks Research Board Members (11)

Name Representing Role Since
Abraham Van Wyk Acquipharma Holdings Board Observer 000 0000
Anand Anandkumar Ph.D Bugworks Research Co-Founder, Chief Executive Officer, Managing Director & Board Member 000 0000
Atsushi Usami Ph.D The University of Tokyo Edge Capital Board Member 000 0000
Kiran Mysore The University of Tokyo Edge Capital Board Observer 000 0000
Pranav Pai 3one4 Capital Board Observer 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Bugworks Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bugworks Research Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Featherlite Trailers Corporation Minority 000 0000 000000 0
Glentec International Corporation Minority 000 0000 000000 0
Kiran Mazumdar-Shaw Angel (individual) Minority 000 0000 000000 0
Kotak Investment Advisors Asset Manager Minority 000 0000 000000 0
Lightrock Impact Investing Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »

Bugworks Research FAQs

  • When was Bugworks Research founded?

    Bugworks Research was founded in 2014.

  • Who is the founder of Bugworks Research?

    Anand Anandkumar Ph.D, Venkataraman Balasubramanian Ph.D, Shahul Hameed, K. Ramanujan, Santanu Datta Ph.D, and Janani Venkatraman are the founders of Bugworks Research.

  • Who is the CEO of Bugworks Research?

    Anand Anandkumar Ph.D is the CEO of Bugworks Research.

  • Where is Bugworks Research headquartered?

    Bugworks Research is headquartered in Saratoga, CA.

  • What is the size of Bugworks Research?

    Bugworks Research has 42 total employees.

  • What industry is Bugworks Research in?

    Bugworks Research’s primary industry is Drug Discovery.

  • Is Bugworks Research a private or public company?

    Bugworks Research is a Private company.

  • What is the current valuation of Bugworks Research?

    The current valuation of Bugworks Research is 00000.

  • What is Bugworks Research’s current revenue?

    The current revenue for Bugworks Research is 000000.

  • How much funding has Bugworks Research raised over time?

    Bugworks Research has raised $41.6M.

  • Who are Bugworks Research’s investors?

    Featherlite Trailers, Glentec International, Kiran Mazumdar-Shaw, Kotak Investment Advisors, and Lightrock are 5 of 23 investors who have invested in Bugworks Research.

  • Who are Bugworks Research’s competitors?

    Venatorx Pharmaceuticals, Destiny Pharma, BioVersys, Entasis Therapeutics, and Synlogic are some of the 25 competitors of Bugworks Research.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »